| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 5.3K | 3.2% | 5.8% |
| Total Income | 5.3K | 3.2% | 5.8% |
| Expenditure | 4.6K | 1.3% | 4.7% |
| PBT | 693.00 | 37.2% | 13.1% |
| Net Profit | 561.00 | 44.2% | 15.4% |
| OPM | 13.96% | 3.92pp | 0.90pp |
| NPM | 10.60% | 3.01pp | 0.89pp |
| EPS | 1.24 | 45.9% | 17.0% |
GE HealthCare Announces CFO Transition; Reports Preliminary Q2 2026 Financial Results
24 Jul 2026 · 24 Jul, 1:52 am
Summary
GE HealthCare announced preliminary second quarter 2026 financial results, reporting a 5.7% year-over-year revenue increase and 3.5% organic revenue growth. The company anticipates diluted EPS and Adjusted EPS growth to exceed previous expectations for the quarter. Management expressed satisfaction with business momentum, citing strong orders, healthy end-market demand, new product traction, and commercial execution. GE HealthCare also reaffirmed its full-year 2026 guidance.
Key Highlights
- 1
GE HealthCare announced preliminary second quarter 2026 results, showing year-over-year Revenue growth of 5.7% and Organic revenue growth of 3.5%.
- 2
The company expects year-over-year growth in diluted Earnings Per Share (EPS) and Adjusted EPS to be ahead of prior expectations for the second quarter.
- 3
GE HealthCare reaffirmed its full-year 2026 guidance, reflecting continued business momentum.
- 4
The company reported preliminary second quarter revenues of $5,295 million, an increase of 5.7% compared to the prior year.
- 5
Organic revenue for the second quarter was $5,182 million, representing a 3.5% increase year-over-year.
- 6
James (Jay) Saccaro will step down as Chief Financial Officer, with George Newcomb appointed as interim CFO.
Management Comments
Peter Arduini
On behalf of the Board of Directors and executive team, I would like to thank Jay for his contributions over the past three years. He has played a key role in driving financial discipline and strategic investments aligned to our capital allocation strategy. We wish him success in his next endeavor. We are pleased with the momentum in our business, reflecting strong orders, healthy end market demand, traction with new products, and continued commercial execution.
James (Jay) Saccaro
It has been a privilege to serve as GE HealthCare's CFO and lead its outstanding finance organization. I want to thank Peter, the Board, and my colleagues for their partnership over the past three years and I wish the company continued success.
Informational and educational content only. Not investment advice.